NCT02347085View on ClinicalTrials.gov

24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003 and Placebo MDI

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

June 1, 2015

Study Completion Date

June 1, 2015

Conditions
COPD
Interventions
DRUG

GFF MDI (PT003)

DRUG

Placebo MDI

Sponsors
All Listed Sponsors
lead

Pearl Therapeutics, Inc.

INDUSTRY